November 25, 2025
Clearside Biomedical Inc., a company that develops treatments for serious eye diseases, received a Delaware bankruptcy judge's permission Tuesday to pay contractors' wages and prepetition taxes as the company kicks off a Chapter 11 case designed to help find a buyer for its assets.
November 24, 2025
Clearside Biomedical, a company developing treatments for eye diseases, has filed for Chapter 11 protection in Delaware bankruptcy court with $64 million in debt, saying it will attempt to sell its business during the case.